Menu
Recruiting NCT07254299

Hypnosis to Improve Well-beings of Critically Ill Patients and Prevent Post-intensive Care Syndrome

No phase Interventional Post Intensive Care Syndrome (PICS)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Hypnosis.
Who it may be relevant to
Registry conditions: Post Intensive Care Syndrome (PICS). Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Switzerland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The goal of this clinical trial is to evaluate the effectiveness of a hypnosis intervention in improving well-being at day 28 of an ICU stay. The main question it aims to answer is : -Does Hypnosis intervention at ICU discharge and on day 7 and 14 on the wards if the patient remains in the hospital, improve wellbeing at 28 days ? Researchers will compare discharged ICU patients who received standard post-discharge care to discharged ICU patients who received standard post-discharge care and hypnosis intervention on discharge and 7 and 14days after if they are still in the hospital, to see if hypnosis can improve their wellbeing. Participants will receive a hypnosis session on the day of ICU discharge, a second session seven days post-discharge and a third session at day 14 if they are still in the hospital.

Detailed description

Critically ill patients in the Intensive Care Unit (ICU) face numerous challenges both acutely and in the long term. These patients frequently experience acute pain and anxiety due to intubation and induced comas. Following their ICU discharge, they commonly report decreased well-being and quality of life. Additionally, up to 40% of critically ill patients develop post-intensive care syndrome (PICS), which includes mental, physical, and cognitive sequelae that can persist up to one year after discharge. Heavy sedation and medications necessary to manage pain and anxiety are known risk factors for PICS.

The current standard of care in the ICU includes mobilization and nutrition, pain control, and family engagement and empowerment. Furthermore, no other specific interventions are aimed at improving long-term outcomes and preventing PICS.

Several studies have explored using hypnosis to improve the acute care of ICU patients. For instance, a pain protocol that included hypnosis in burn patients hospitalized in the CHUV (Centre Hospitalier Universitaire Vaudois) resulted in reduced pain intensity, reduced opioid use, reduced anxiety, and better wound outcomes, all while lowering costs. A pilot study involving non-invasive ventilation patients showed that hypnosis could improve comfort, mask tolerance, and anxiety levels. Additionally, studies on relaxation therapy have indicated that electronic relaxation therapy is a promising, safe, and effective non-pharmacological solution to enhance overall comfort in alert and non-delirious ICU patients.

However, despite these efforts, there is a lack of efficient interventions specifically targeting the wellbeing of patients after an ICU stay and the prevention of PICS. Existing interventions, such as follow-up programs, rehabilitation, and psychological follow-up, have shown conflicting results. To date, no studies have specifically assessed the effect of hypnosis on the short and longer-term well-being of critically ill patients leaving the ICU and its possible effect on the prevention of PICS.

The investigators hypothesize that providing a hypnosis session at ICU discharge and followed by subsequent sessions on days 7 and 14 on the ward will improve well-being in the short term and reduce PICS symptoms at 3-months. The primary outcome will be the assessment of well-being at day 28 post-ICU discharge. Secondary outcomes will be anxiety, depression, PTSD, and quality of life at three months.

Hypothesis and primary objective The investigators hypothesize that providing intervention with hypnosis at ICU discharge and subsequent sessions on day 7 and 14 on the ward if the patient remains in the hospital will improve wellbeing at day 28 and reduce PICS symptoms at three months in critically ill patients.

Primary Objective:

The primary objective of this study is to evaluate the effectiveness of a hypnosis intervention in improving well-being at day 28 of an ICU stay.

Scale used for wellbeing:

* ESAS, total 90, each item on a 0-10 scale * EQ-5D-5L

Secondary Objectives:

1. To assess the impact of a hypnosis intervention to improve PICS at 3 months

* Anxiety and depression: PHQ-9 et GAD-7 * Post-traumatic stress disorder: PDI and IES-R scale * Quality of life: SF-12, EQ-5D-5L and WHODAS 2.0 * Patient impression of change: PGIC 2. To evaluate patient immediate wellbeing after the hypnosis intervention. • ESAS before after the session in patients who will get the session

Interventions

  • Other Hypnosis
    the hypnosis will be tailored to each patient. Key elements will include relaxation (to mitigate anxiety and stress and help the patient feel more comfortable, secure, and competent), reassociation techniques (to help the patient reconnect with their body, promoting a sense of embodiment and presence), and safe place (to introduce a safe and calming place to instill a sense of control and competence, aiding in emotional stabilization and fostering a sense of safety and well-being).

Primary outcome measures

  • Wellbeing at day 28 post intensive care unit discharge [Time frame: Day 28 post intensive care unit discharge]
Secondary outcome measures (7)
  • Immediate wellbeing following a hypnosis session [Time frame: Day 1 (Day of discharge from ICU), day 7, day 14]
  • PDI - Peritraumatic distress inventory [Time frame: day 28 post ICU discharge]
  • PHQ-9 - Patient Health Questionnaire-9 [Time frame: Day 28 post intensive care unit discharge and 3 months post intensive care]
  • GAD-7 - Generalized Anxiety Disorder-7 [Time frame: at day 28 and 3 months post ICU discharge]
  • IES-R (Impact of event Scale) [Time frame: 3 months post intensive care unit discharge. Higher score means more PTSD symptoms.]
  • EQ-5D-5L (Quality of life) [Time frame: Day 28 post intensive care unit discharge and 3 months post intensive care unit discharge]
  • PGIC - Patient Global Impression of Change [Time frame: Day 28 post intensive care unit discharge and 3 months post intensive care unit discharge]

Eligibility criteria

Inclusion criteria

  • On Mechanical Ventilation for at least 2 days
  • Able to give informed consent as documented by signature
  • French speaking

Exclusion criteria

  • Refusal of the patient
  • Patient transferred from another ICU
  • Patient is planned for a withdrawal of care or is actively dying
  • Glasgow coma scale (GCS) <15 on ICU discharge
  • Patient presenting with delirium (detected by CAM-ICU) on ICU discharge
  • Patient hospitalized for traumatic brain injury
  • Patient is in jail
  • Patient hospitalized for more than 28 days in the ICU

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Prevention

Study locations

Switzerland · 2 centers
  • University Hospital of Geneva — Geneva
  • Hôpitaux Neuchâtelois — Neuchâtel

Publications

  • Schmidt B, Schneider J, Deffner T, Rosendahl J. Hypnotic suggestions of safety improve well-being in non-invasively ventilated patients in the intensive care unit. Intensive Care Med. 2021 Apr;47(4):485-486. doi: 10.1007/s00134-021-06364-8. Epub 2021 Feb 16. No abstract available. PMID 33590259
  • Spiegel D, Cardena E. New uses of hypnosis in the treatment of posttraumatic stress disorder. J Clin Psychiatry. 1990 Oct;51 Suppl:39-43; discussion 44-6. PMID 2211565

Identifiers

NCT: NCT07254299 · 2025-00369

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗